Press Release
Pheonix Research Releases 2026–2033 Pharmacy Automation Forecast: USD 6.18 Billion Today, USD 11.24 Billion by 2033, With 8,000 Fewer Pharmacies Buying It
FOR IMMEDIATE RELEASE
18 November 2026 — Pheonix Research today publishes Global Pharmacy Automation System Market Report, Size, Share and Forecast 2026–2033, which sizes the global pharmacy automation market at USD 6,180 million in 2025 and forecasts USD 11,240 million by 2033 — a 7.76 per cent compound annual growth rate and USD 5,060 million of new value.
The report’s central finding is a widening gap between value and volume. Unit shipments rise from 62,400 systems to 91,500 over the same period, 4.90 per cent a year, while revenue per installed system grows from USD 99,038 to USD 122,842 — 2.73 per cent a year. Value compounds more than half again as fast as the machine count, and the report attributes the gap to mix rather than to price inflation.
“A health system that closes twenty-one hospital pharmacies and serves all of them from one robotic hub buys fewer machines and more automation per machine,” said the Pheonix Research healthcare devices team. “That is the trade this market is now built on.”
Key findings
- The buyer base is contracting. The United States has almost 8,000 fewer retail pharmacies than it did in 2018 and lost more than 2,000 in 2025 alone, with Rite Aid liquidated. Total US prescription dispensing revenue nonetheless reached a record USD 751 billion in 2025, up 10 per cent, because growth is concentrated in specialty drugs dispensed largely outside retail chains.
- The hospital sale is deep at the point of care and shallow everywhere else. In the 2023 ASHP national survey of 1,497 general and children’s hospitals, 86.1 per cent used automated dispensing cabinets as their primary maintenance-dose distribution method. 27.0 per cent had a high-density carousel, 6.5 per cent a robot dispensing unit doses, 2.0 per cent a robot as primary central distribution, and 3.7 per cent any automation for compounding sterile preparations. 52.7 per cent reported no IV workflow technology at all.
- The fastest-growing families are the least installed. IV and sterile compounding automation grows at 10.10 per cent and central robotics at 9.54 per cent, against automated dispensing cabinets at 6.81 per cent and table-top counters at 5.14 per cent.
- Under half the market can be reconciled to a filing. Named, disclosed vendor pools carry 46.68 per cent of the 2025 base — Omnicell USD 1,185 million for fiscal 2025, BD’s Medication Management Solutions USD 835 million in the December quarter, and Tosho JPY 29.5 billion. The remaining 53.32 per cent is a bottom-up estimate and is labelled as one.
- The recurring layer is unbuilt. Barcode verification of doses runs at 73.6 per cent of US hospitals and advanced analytics at 5.7 per cent. Software and service subscriptions are being sold into a base that has not yet bought them.
“The cabinet sale has largely been made and the compounding-suite sale has not,” the team said. “That is why sterile compounding automation grows at half again the rate of cabinets. It is also why the constraint on this market is not clinical appetite. It is capital, floor space, and the difficulty of rebuilding a pharmacy that cannot stop dispensing while you rebuild it.”
Scenarios, and the assumption that carries the forecast
The base case reaches USD 11,240 million in 2033 at 7.76 per cent. A bull case at 9.31 per cent, or USD 12,600 million, requires sterile compounding automation to pass 10 per cent hospital penetration by 2030 and central-fill construction to pull forward. A bear case at 6.00 per cent, or USD 9,850 million, requires retail closure to outrun central-fill construction and hospital capital to defer one full refresh cycle. The report states its own most fragile input: one point off the 2.73 per cent realisation assumption, holding units constant, moves 2033 value to approximately USD 10,400 million.
Report details
- Title: Global Pharmacy Automation System Market Report, Size, Share and Forecast 2026–2033: The Pharmacy Count Fell by Eight Thousand and Automation Grew Anyway
- Base year and horizon: 2025 base, forecast to 2033.
- Coverage: global, by equipment family and region — automated dispensing cabinets, central pharmacy robotics, carousels and vertical storage, table-top counters, IV and sterile compounding automation, unit-dose packaging, and the associated software and services layer.
- Chapters: market sizing and forecast; value chain and cost structure; technology and innovation; competitive landscape, including a revenue reconciliation against disclosed vendor results; investment activity; market risk and scenarios; regulatory landscape covering device clearance, USP <797> and <800>, and reimbursement.
- Methodology: a 70/30 split of secondary and primary research. Primary work covers price bands, the specification chain, switching behaviour and payback arithmetic; market size is modelled from secondary disclosure. No market-research competitor data is used as an input, and every estimated pool is shown against the disclosed pool it sits beside.
- Available at: pheonixresearch.com/healthcare/medical-devices/market-report/pharmacy-automation-system-market/
About Pheonix Research
Pheonix Research is a market intelligence platform that queries a live graph of more than 500 market nodes to surface leading signals and translate them into role-specific decisions. It publishes market reports across industrial, healthcare and technology sectors, built from disclosed primary sources, a structured primary research programme, and a documented model in which every estimated figure is identified as an estimate.
Media contact
Pheonix Research
Research & Intelligence: [email protected]
Sales & Engagements: [email protected]
Website: www.pheonixresearch.com
— Ends —
